🔎 Trials Near Me

Почетна › Steatotna bolest jetre › Arizona › Tucson

Kliničke studije za Steatotna bolest jetre u gradu Tucson, AZ

10 studija za Steatotna bolest jetre traži učesnike na lokacijama u gradu Tucson i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Тражи се учесникФаза 2
  • GSK Investigational Site, Tucson
  • GSK Investigational Site, Tucson
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06613698

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Тражи се учесникФаза 3
  • Akero Clinical Study Site, Tucson
  • Akero Clinical Study Site, Tucson
  • Akero Clinical Study Site, Tucson
  • и још 1
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Тражи се учесникФаза 2
  • Adobe Clinical Research, Tucson
  • The Institute for Liver Health II LLC dba Arizona Liver Health, Tucson
  • Del Sol Research Management, LLC, Tucson
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07631637

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Тражи се учесникФаза 2
  • Adobe Clinical Research, LLC, Tucson
  • Arizona Liver Health - Tucson, Tucson
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Тражи се учесникФаза 2
  • GSK Investigational Site, Tucson
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT06920043

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Тражи се учесникФаза 3
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Тражи се учесникФаза 3
  • 89bio Clinical Study Site, Tucson
  • 89bio Clinical Study Site, Tucson
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Тражи се учесникФаза 3
  • The Institute for Liver Health II dba Arizona Clinical Trials - Tucson, Tucson
  • Del Sol Research Management, LLC, Tucson
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Тражи се учесникФаза 2
  • Arizona Liver Health - Tucson, Tucson
Узраст од 18 до 75 · Оба пола · Ажурирано 29. 9. 2026. · NCT07527910

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Тражи се учесникФаза 3
  • GSK Investigational Site, Tucson
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227

Studije za Steatotna bolest jetre u drugim gradovima

Ostale studije u gradu Tucson

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.